Understanding this disease and reimagining the future of care
Addressing risk of recurrence after an early-stage diagnosis
Our commitment to patients
We recognize that navigating life after an eBC diagnosis is hard, so we have worked with key partners in the advocacy community to build a space of support, helping patients move forward with confidence, equipped with better understanding about their risk of cancer coming back. To learn more visit UnderstandeBCRisk.com.
Any breast cancer diagnosis can be difficult for patients, their families, and loved ones, but a diagnosis of advanced or metastatic disease can be especially devastating. Metastatic breast cancer (mBC) occurs when the disease spreads beyond the breast, even after initial treatment.9
There is no cure for mBC, yet scientists are making real progress in cancer research and developing treatments. Novartis continues to be committed to the mBC community, focusing on the priority for patients to live longer, and remain able to enjoy things in life they love.
The More Than Just Words Initiative, Promoting Equity in Breast Cancer Care
Black women are 41% more likely to die from breast cancer than their white counterparts in the United States. Novartis believes that all breast cancer patients, regardless of race, ethnicity, or socioeconomic status, should have the same opportunity to experience a “Life filled with Living”.10 That is why we launched More Than Just Words, a multiyear commitment to promote health equity in breast cancer care, where there is significant unmet need, to transform outcomes for all patients.